The INSPIRE Pipeline™ Shield Post Approval Study aims to gather data on how well the Pipeline™ Flex Embolization Device with Shield Technology™ works for treating intracranial aneurysms (IA), which are bulges in blood vessels in the brain. This study is done in the real-world setting of the United States after the device has been approved for use. The study is observational, meaning doctors watch and record how the device is used without changing the treatment. It's a single-arm study, which means everyone involved uses the same treatment. This study is part of a larger project called the Product Surveillance Registry.

• Participation Length: You will be involved for the duration of the treatment and follow-up.
• Eligibility: Participants must have consented and be treated with the Pipeline™ Shield Device.
• Exclusions: You cannot participate if you are pregnant, breastfeeding, or in another study that conflicts.